Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 3
2021 7
2022 5
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Treatment management for BRAF-mutant melanoma patients with tumor recurrence on adjuvant therapy: a multicenter study from the prospective skin cancer registry ADOREG.
Haist M, Stege H, Rogall F, Tan Y, von Wasielewski I, Klespe KC, Meier F, Mohr P, Kähler KC, Weichenthal M, Hauschild A, Schadendorf D, Ugurel S, Lodde G, Zimmer L, Gutzmer R, Debus D, Schilling B, Kreuter A, Ulrich J, Meiss F, Herbst R, Forschner A, Leiter U, Pfoehler C, Kaatz M, Ziller F, Hassel JC, Tronnier M, Sachse M, Dippel E, Terheyden P, Berking C, Heppt MV, Kiecker F, Haferkamp S, Gebhardt C, Simon JC, Grabbe S, Loquai C. Haist M, et al. Among authors: stege h. J Immunother Cancer. 2023 Sep;11(9):e007630. doi: 10.1136/jitc-2023-007630. J Immunother Cancer. 2023. PMID: 37730278 Free PMC article.
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial.
Becker JC, Ugurel S, Leiter U, Meier F, Gutzmer R, Haferkamp S, Zimmer L, Livingstone E, Eigentler TK, Hauschild A, Kiecker F, Hassel JC, Mohr P, Fluck M, Thomas I, Garzarolli M, Grimmelmann I, Drexler K, Spillner AN, Eckhardt S, Schadendorf D; DeCOG. Becker JC, et al. Lancet. 2023 Sep 2;402(10404):798-808. doi: 10.1016/S0140-6736(23)00769-9. Epub 2023 Jul 11. Lancet. 2023. PMID: 37451295 Clinical Trial.
Seborrhoische Keratosen.
Barthelmann S, Butsch F, Lang BM, Stege H, Großmann B, Schepler H, Grabbe S. Barthelmann S, et al. Among authors: stege h. J Dtsch Dermatol Ges. 2023 Mar;21(3):265-278. doi: 10.1111/ddg.14984_g. J Dtsch Dermatol Ges. 2023. PMID: 36929560
Seborrheic keratosis.
Barthelmann S, Butsch F, Lang BM, Stege H, Großmann B, Schepler H, Grabbe S. Barthelmann S, et al. Among authors: stege h. J Dtsch Dermatol Ges. 2023 Mar;21(3):265-277. doi: 10.1111/ddg.14984. Epub 2023 Mar 9. J Dtsch Dermatol Ges. 2023. PMID: 36892019 Review.
Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg Registry.
Haist M, Stege H, Lang BM, Tsochataridou A, Salzmann M, Mohr P, Schadendorf D, Ugurel S, Placke JM, Weichenthal M, Gutzmer R, Leiter U, Kaatz M, Haferkamp S, Berking C, Heppt M, Tschechne B, Schummer P, Gebhardt C, Grabbe S, Loquai C. Haist M, et al. Among authors: stege h. Cancers (Basel). 2022 Nov 11;14(22):5543. doi: 10.3390/cancers14225543. Cancers (Basel). 2022. PMID: 36428636 Free PMC article.
Protease- and cell type-specific activation of protease-activated receptor 2 in cutaneous inflammation.
Fleischer MI, Röhrig N, Raker VK, Springer J, Becker D, Ritz S, Bros M, Stege H, Haist M, Grabbe S, Haub J, Becker C, Reyda S, Disse J, Schmidt T, Mahnke K, Weiler H, Ruf W, Steinbrink K. Fleischer MI, et al. Among authors: stege h. J Thromb Haemost. 2022 Dec;20(12):2823-2836. doi: 10.1111/jth.15894. Epub 2022 Oct 12. J Thromb Haemost. 2022. PMID: 36161697 Free article.
eHealth Literacy in German Skin Cancer Patients.
Stege H, Schneider S, Forschner A, Eigentler T, Nashan D, Huening S, Meiss F, Lehr S, Kaatz M, Kuchen R, Kaehler KC, Haist M, Huebner J, Loquai C. Stege H, et al. Int J Environ Res Public Health. 2022 Jul 8;19(14):8365. doi: 10.3390/ijerph19148365. Int J Environ Res Public Health. 2022. PMID: 35886215 Free PMC article.
23 results